An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Guideline: Alternative Mass Drug Administration Regimens to Eliminate Lymphatic Filariasis.
Geneva: World Health Organization; 2017.
Top results in this bookTable of Contents
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
Addendum to managing complications (chapter 6) of clinical guideline 81, advanced breast cancer.
London: National Institute for Health and Care Excellence (NICE); 2014 May. (Clinical guideline, No. 81.1.)
Advanced breast cancer: diagnosis and treatment.
London: National Institute for Health and Care Excellence (NICE); 2017 Aug. (NICE Clinical Guidelines, No. 81.)
Ovarian Cancer: The Recognition and Initial Management of Ovarian Cancer.
Cardiff (UK): National Collaborating Centre for Cancer (UK); 2011 Apr. (NICE Clinical Guidelines, No. 122.)
Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin.
Cardiff (UK): National Collaborating Centre for Cancer (UK); 2010 Jul. (NICE Clinical Guidelines, No. 104.)
Early and locally advanced breast cancer: diagnosis and management.
London: National Institute for Health and Care Excellence (NICE); 2024 Jan 16. (NICE Guideline, No. 101.)
Management of IRIS [Internet].
Brust JCM, McGowan JP, Fine SM, et al.
Baltimore (MD): Johns Hopkins University; 2024 Mar.
Sacituzumab Govitecan (Trodelvy): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with unresectable locally advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative (IHC 0, IHC 1+, or IHC 2+/ISH–) breast cancer who have received endocrine-based therapy and at least 2 additional systemic therapies in the metastatic setting [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Feb.
Nivolumab and Relatlimab (Opdualag): CADTH Reimbursement Recommendation: Indication: For the treatment of adult and pediatric patients 12 years of age or older with unresectable or metastatic melanoma who have not received prior systemic therapy for unresectable or metastatic melanoma [Internet].
Addendum to Clinical Guideline 144, Venous thromboembolic diseases in adults: diagnosis, management and thrombophilia testing.
London: National Institute for Health and Care Excellence (NICE); 2015 Nov. (Clinical Guideline Addendum, No. 144.1.)
Pembrolizumab (Keytruda): CADTH Reimbursement Recommendation: Indication: Adjuvant treatment of adult and pediatric (12 years and older) patients with stage IIB or IIC melanoma following complete resection [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Nov.
Melanoma: assessment and management.
London: National Institute for Health and Care Excellence (NICE); 2022 Jul 27. (NICE Guideline, No. 14.)
Substance Abuse Treatment for Persons With HIV/AIDS [Internet].
Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2000. (Treatment Improvement Protocol (TIP) Series, No. 37.)
Medicines Optimisation: The Safe and Effective Use of Medicines to Enable the Best Possible Outcomes.
NICE Medicines and Prescribing Centre (UK).
Manchester: National Institute for Health and Care Excellence (NICE); 2015 Mar. (NICE Guideline, No. 5.)
Guidelines on the Treatment of Skin and Oral HIV-Associated Conditions in Children and Adults.
Geneva: World Health Organization; 2014.
WHO Guidelines on Drawing Blood: Best Practices in Phlebotomy.
Geneva: World Health Organization; 2010.
WHO Best Practices for Injections and Related Procedures Toolkit.
Geneva: World Health Organization; 2010 Mar.
Comprehensive Cervical Cancer Control: A Guide to Essential Practice. 2nd edition.
Global Guidelines for the Prevention of Surgical Site Infection.
Geneva: World Health Organization; 2018.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on